Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy; School of Medicine, Vita-Salute San Raffaele University, Milan, Italy.
Department of Anesthesiology and Intensive Care, E. Meshalkin National Medical Research Center, Novosibirsk, Russia; Department of Anesthesiology and Intensive Care, Novosibirsk State University, Novosibirsk, Russia.
J Cardiothorac Vasc Anesth. 2022 Aug;36(8 Pt A):2454-2462. doi: 10.1053/j.jvca.2022.01.001. Epub 2022 Jan 7.
To investigate the effect of volatile anesthetics on the rates of postoperative myocardial infarction (MI) and cardiac death after coronary artery bypass graft (CABG).
A post hoc analysis of a randomized trial.
Cardiac surgical operating rooms.
Patients undergoing elective, isolated CABG.
Patients were randomized to receive a volatile anesthetic (desflurane, isoflurane, or sevoflurane) or total intravenous anesthesia (TIVA). The primary outcome was hemodynamically relevant MI (MI requiring high-dose inotropic support or prolonged intensive care unit stay) occurring within 48 hours from surgery. The secondary outcome was 1-year death due to cardiac causes.
A total of 5,400 patients were enrolled between April 2014 and September 2017 (2,709 patients randomized to the volatile anesthetics group and 2,691 to TIVA). The mean age was 62 ± 8.4 years, and the median baseline ejection fraction was 57% (50-67), without differences between the 2 groups. Patients in the volatile group had a lower incidence of MI with hemodynamic complications both in the per-protocol (14 of 2,530 [0.6%] v 27 of 2,501 [1.1%] in the TIVA group; p = 0.038) and as-treated analyses (16 of 2,708 [0.6%] v 29 of 2,617 [1.1%] in the TIVA group; p = 0.039), but not in the intention-to-treat analysis (17 of 2,663 [0.6%] v 28 of 2,667 [1.0%] in the TIVA group; p = 0.10). Overall, deaths due to cardiac causes were lower in the volatile group (23 of 2,685 [0.9%] v 40 of 2,668 [1.5%] than in the TIVA group; p = 0.03).
An anesthetic regimen, including volatile agents, may be associated with a lower rate of postoperative MI with hemodynamic complication in patients undergoing CABG. Furthermore, it may reduce long-term cardiac mortality.
探讨吸入麻醉与全凭静脉麻醉对冠状动脉旁路移植术(CABG)后心肌梗死(MI)和心脏死亡的影响。
一项随机试验的事后分析。
心脏外科手术室。
接受择期、单纯 CABG 的患者。
患者随机接受吸入麻醉(地氟烷、异氟烷或七氟烷)或全凭静脉麻醉(TIVA)。主要结局是术后 48 小时内发生的血流动力学相关 MI(需要高剂量正性肌力支持或延长重症监护病房停留时间的 MI)。次要结局是 1 年因心脏原因导致的死亡。
2014 年 4 月至 2017 年 9 月期间共纳入 5400 例患者(2709 例随机分配至吸入麻醉组,2691 例分配至 TIVA 组)。平均年龄为 62±8.4 岁,中位基线射血分数为 57%(50-67),两组间无差异。在符合方案人群中(TIVA 组 2530 例中有 14 例[0.6%],TIVA 组 2501 例中有 27 例[1.1%];p=0.038)和实际治疗人群中(TIVA 组 2708 例中有 16 例[0.6%],TIVA 组 2617 例中有 29 例[1.1%];p=0.039),与 TIVA 组相比,吸入组 MI 发生率较低,但在意向治疗分析中(TIVA 组 2663 例中有 17 例[0.6%],TIVA 组 2667 例中有 28 例[1.0%];p=0.10),无统计学差异。总体而言,与 TIVA 组(2685 例中有 23 例[0.9%])相比,吸入组因心脏原因导致的死亡人数较少(2668 例中有 40 例[1.5%])(p=0.03)。
包括挥发性药物在内的麻醉方案可能与 CABG 术后血流动力学并发症相关的 MI 发生率降低有关。此外,它可能降低长期心脏死亡率。